# Understanding GLP-1 Receptor Agonist Costs with Our 2025 Price Calculator > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/glp-1-receptor-agonist-cost-calculator-semaglutide-2025/ > **Published:** 2026-04-13T13:17:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:05:49-04:00 > **Clinical Summary:** Use our GLP-1 receptor agonist cost calculator to estimate semaglutide out-of-pocket prices in 2025 and understand insurance coverage impacts. --- GLP-1 Clinical Relevance  #43Contextual Information  Background context; limited direct clinical applicability. ⚕ GLP-1 News  |  CED Clinic GLP-1 Cost CalculatorNews[Patient Cost](https://cedclinic.com/michigan-marijuana-tax-lawsuit-challenge/) ToolSemaglutideTirzepatideGLP-1 Receptor Agonist[Insurance Coverage](https://cedclinic.com/workers-compensation-medical-cannabis-chronic-pain-coverage/)Medicare AccessObesity Treatment[Weight Management](https://cedclinic.com/cannabis-metabolism-weight-management-science/)Out-of-Pocket CostsMedication Affordability Why This Matters Family medicine clinicians routinely encounter cost as the primary barrier to GLP-1 initiation and adherence, making accurate out-of-pocket estimates a practical necessity in the clinical encounter. Variability in coverage across Medicare, Medicaid, and commercial plans directly affects which agent a patient can sustain long-term, influencing prescribing decisions beyond clinical indication alone. Understanding a patient’s true cost burden allows the clinician to anticipate non-adherence, plan appropriate follow-up intervals, and counsel on manufacturer savings programs before gaps in therapy occur. Clinical Takeaway GLP-1 receptor agonists like semaglutide and tirzepatide carry widely variable out-of-pocket costs depending on insurance type, indication, and formulary status, making cost transparency a practical barrier to initiating and sustaining therapy. Medicare currently covers these medications for diabetes management but does not broadly cover them for obesity alone, which creates significant access gaps for patients who qualify clinically but not administratively. Medicaid coverage varies by state, and commercial insurance policies differ substantially in prior authorization requirements and tier placement. When counseling patients in a family medicine setting, proactively walking through cost estimates before prescribing, rather than after, reduces the likelihood of treatment abandonment due to sticker shock at the pharmacy counter. Dr. Caplan’s Take “The cost conversation is inseparable from the clinical conversation when it comes to GLP-1 therapy, and tools like this calculator help bridge that gap in a meaningful way. In my practice, I have found that patients who understand their out-of-pocket burden before we finalize a treatment plan are far more likely to stay adherent over the long term, which is ultimately what drives metabolic outcomes. The persistent coverage disparities between Ozempic for diabetes and Wegovy for obesity, despite their pharmacological overlap, remain one of the most frustrating barriers I navigate with patients weekly. When I introduce a GLP-1 regimen, I now routinely walk through cost scenarios alongside the clinical rationale, because a prescription that a patient cannot afford is not a treatment plan, it is a missed opportunity.” Clinical Perspective Cost remains one of the most significant barriers to initiating and maintaining GLP-1 receptor agonist therapy, and real-world discontinuation rates are heavily driven by out-of-pocket burden rather than clinical failure or tolerability. As Medicare coverage for obesity-indicated GLP-1s remains inconsistently applied and commercial formularies vary widely, clinicians are often prescribing into a financial landscape their patients cannot sustain. One concrete action is to routinely incorporate a cost and coverage check into the prescribing workflow before the patient leaves the visit, using available calculators to identify manufacturer savings programs, formulary alternatives, or compounded options where appropriate, so that the conversation about affordability happens proactively rather than at the pharmacy counter. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20%3Cb%3EGLP-1%20Cost%3C%2Fb%3E%20Calculator%202025%20%E2%80%94%20%3Cb%3EOzempic%3C%2Fb%3E%2C%20Wegovy%2C%20Mounjaro%20Prices%20%40drcaplan&url=https%3A%2F%2Fglp1costcalculator.com%2Fcalculator%2Fsavings-card)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fglp1costcalculator.com%2Fcalculator%2Fsavings-card)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20%3Cb%3EGLP-1%20Cost%3C%2Fb%3E%20Calculator%202025%20%E2%80%94%20%3Cb%3EOzempic%3C%2Fb%3E%2C%20Wegovy%2C%20Mounjaro%20Prices%20--%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fglp1costcalculator.com%2Fcalculator%2Fsavings-card)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/glp-1-news/feed/) 📰 Source: [https://glp1costcalculator.com/calculator/savings-card](https://glp1costcalculator.com/calculator/savings-card) Table of Contents - [FAQ](#FAQ)[How much does Ozempic typically cost per month in 2025?](#How_much_does_Ozempic_typically_cost_per_month_in_2025) - [Does Medicare cover GLP-1 medications like Wegovy or Zepbound?](#Does_Medicare_cover_GLP-1_medications_like_Wegovy_or_Zepbound) - [Is Mounjaro covered by Medicaid for weight loss?](#Is_Mounjaro_covered_by_Medicaid_for_weight_loss) - [What is the difference in cost between Ozempic and Wegovy?](#What_is_the_difference_in_cost_between_Ozempic_and_Wegovy) - [Are there manufacturer savings programs that can reduce my GLP-1 costs?](#Are_there_manufacturer_savings_programs_that_can_reduce_my_GLP-1_costs) - [How accurate is an online GLP-1 cost calculator?](#How_accurate_is_an_online_GLP-1_cost_calculator) - [Why does my insurance cover Ozempic for diabetes but not Wegovy for weight loss?](#Why_does_my_insurance_cover_Ozempic_for_diabetes_but_not_Wegovy_for_weight_loss) - [What happens to my GLP-1 costs if I reach my insurance deductible?](#What_happens_to_my_GLP-1_costs_if_I_reach_my_insurance_deductible) - [Are compounded versions of semaglutide or tirzepatide cheaper, and are they safe?](#Are_compounded_versions_of_semaglutide_or_tirzepatide_cheaper_and_are_they_safe) - [Can I use an HSA or FSA to pay for GLP-1 medications?](#Can_I_use_an_HSA_or_FSA_to_pay_for_GLP-1_medications) - [Related](#Related) ## FAQ #### How much does Ozempic typically cost per month in 2025? The list price of Ozempic can exceed $900 per month without insurance, but what you actually pay depends heavily on your specific insurance plan, formulary tier, and any manufacturer savings programs you apply. Using a GLP-1 cost calculator can give you a personalized estimate based on your coverage before you fill your first prescription. #### Does Medicare cover GLP-1 medications like Wegovy or Zepbound? Medicare Part D now covers semaglutide (Wegovy) and tirzepatide (Zepbound) for [weight management](https://cedclinic.com/cannabis-metabolism-weight-management-science/) in patients who meet specific criteria, following recent policy changes, though coverage details vary by plan. It is important to review your specific Part D formulary, as cost-sharing and tier placement differ between plans and can significantly affect your out-of-pocket costs. #### Is Mounjaro covered by Medicaid for weight loss? Medicaid coverage for Mounjaro and other GLP-1 medications varies widely by state, as each state administers its own formulary and prior authorization requirements. Some states cover tirzepatide only for type 2 diabetes indications, so confirming your state’s specific policy before initiating therapy is essential. #### What is the difference in cost between Ozempic and Wegovy? Ozempic and Wegovy both contain semaglutide but are FDA-approved for different indications, and their [insurance coverage](https://cedclinic.com/workers-compensation-medical-cannabis-chronic-pain-coverage/) and pricing structures reflect those distinctions. Wegovy is approved for chronic weight management, which affects which insurance benefits apply, while Ozempic is approved for type 2 diabetes, meaning the same medication can carry a very different price tag depending on the indication billed. #### Are there manufacturer savings programs that can reduce my GLP-1 costs? Novo Nordisk and Eli Lilly offer savings cards and patient assistance programs that can substantially reduce out-of-pocket costs for eligible commercially insured patients. These programs generally do not apply to patients using Medicare or Medicaid, so eligibility must be confirmed before relying on them as a cost reduction strategy. #### How accurate is an online GLP-1 cost calculator? A well-designed cost calculator uses your insurance type, plan details, and current formulary data to generate a realistic estimate of what you would pay at the pharmacy. These tools provide useful guidance but should be verified with your pharmacist or insurance benefits manager before making treatment decisions. #### Why does my insurance cover Ozempic for diabetes but not Wegovy for weight loss? Insurance plans frequently maintain separate coverage criteria for diabetes medications versus obesity treatments, even when the active ingredient is identical. This reflects longstanding policy distinctions between metabolic disease categories, and the situation is actively evolving as obesity gains broader recognition as a chronic medical condition deserving equivalent coverage. #### What happens to my GLP-1 costs if I reach my insurance deductible? Once you meet your annual deductible, your cost-sharing shifts to copayments or coinsurance, which can meaningfully lower your monthly GLP-1 expense depending on your plan design. Timing your prescription initiation relative to your deductible cycle is a legitimate cost management strategy worth discussing with your prescribing physician. #### Are compounded versions of semaglutide or tirzepatide cheaper, and are they safe? Compounded GLP-1 medications are typically less expensive than brand-name versions, but they are not FDA-approved and lack the same manufacturing oversight, potency verification, and safety data as commercially produced products. The FDA has issued warnings regarding compounded semaglutide and tirzepatide, and patients should discuss the regulatory and clinical risks with their physician before considering this option. #### Can I use an HSA or FSA to pay for GLP-1 medications? GLP-1 medications prescribed for a qualifying medical condition, such as type 2 diabetes or obesity, are generally eligible expenses under Health Savings Accounts and Flexible Spending Accounts. Confirming eligibility with your plan administrator is advisable, particularly if the prescription is written for weight management, as documentation requirements can vary. Nationwide GLP-1 Care Looking for thoughtful, physician-led GLP-1 guidance? CED Clinic offers GLP-1 and metabolic guidance across the United States, including evaluation, prescribing support, side-effect management, and longer-term follow-up for people seeking careful, personalized care. [Learn More](https://cedclinic.com/metabolic/) [Book Now](https://book.squareup.com/appointments/kn3vehwoiz6to6/location/DPV0VF8Y74WA7/services) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [GLP-1 Receptor Agonist Clinical Evidence: Drug Comparisons](https://cedclinic.com/tirzepatide-dual-agonist-weight-loss-comparison/) Explore detailed clinical comparisons of GLP-1 receptor agonists to understand their efficacy and safety profiles. [Read Clinical Evidence](https://cedclinic.com/tirzepatide-dual-agonist-weight-loss-comparison/) [Semaglutide Weight Management Medicine: Real Cost Data](https://cedclinic.com/semaglutide-weight-management-medicine-cost-access/) Review real-world cost data for semaglutide in weight management to better understand financial considerations. [View Cost Data](https://cedclinic.com/semaglutide-weight-management-medicine-cost-access/) [Semaglutide vs Tirzepatide: Clinical Evidence Compared](https://cedclinic.com/semaglutide-tirzepatide-clinical-comparison/) Compare [clinical evidence](https://cedclinic.com/academic-partnerships-cannabis-research/) for semaglutide and tirzepatide to inform treatment choices and cost discussions. [Compare Now](https://cedclinic.com/semaglutide-tirzepatide-clinical-comparison/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).